Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.
The 2025 edition of the European Society for Medical Oncology(ESMO) was held this week in Berlin, delve into its key ...
From heart disease to neurodegeneration, Novartis makes bold deals in 2025 to expand its drug pipeline globally.
With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback